Molecular Tumor Board 2025-2026

Overview

Se trata de un curso que nace a raíz de una de las sesiones formativas que realiza cada 15 días el Servicio de Oncología Médica del Hospital Clínic de Barcelona (HCB). En este curso se presentan casos clínicos simulando un MTB de tumores sólidos, con un objetivo principal, mejorar el conocimiento específico del impacto clínico del perfil molecular en tumores sólidos. Está destinado a médicos oncólogos y a estudiantes y profesionales vinculados a la oncología médica. Cada seminario que conforma el curso lo presenta un profesional de una patología diferente del Servicio de Oncología Médica del HCB.

Syllabus

Precision medicine in melanoma by Dr. Francisco Aya

Melanoma Cancer

Precision medicine in rare pancreatic cancer by Dra. Laura González

Gynaecological Cancer

The Young face of Lung Cancer: an emerging global health challenge by Dra. Teresa Gorría

Lung Cancer

Mismatch repair deficiency in Olfactory Neuroblastoma (Esthesioneuroblastoma) by Dr. Manuel Mazariegos

Head and Neck Cancer

Interpreting molecular results in HER2+/HR+ eBC by Dra. Olga Martínez

Breast Cancer

Targeting uncommon molecular alterations in metastatic prostate cancer by Dra. Marta García de Herreros

Gynaecological Cancer

Precision oncology in young patients with breast cancer: A Different Disease?by Dra. Isabel García-Fructuoso

Breast Cancer

Finding the Bright side of Cholangiocarcinoma by Dra. Lina Candia

Upper GI tumor

Her2 expression in salivary gland cancers by Dra. Carla Climent

Head and Neck Cancer

A Case of Glioblastoma with NTRK Fusion: New Hope for an Old Foe? by Dra. Clara Rodrigo
Is HER2 the new hope for urothelial carcinoma? by Dra. Laura Ferrer
Androgen complete blockage in Salivary Gland Tumor Therapy by Dra. Sandra Andrés
ESR1 mutations as an actionable target for novel endocrine agents in metastatic breast cancer: a representative clinical case by Dr. Francesco Schettini

Breast cancer

When the biology speaks louder than the years by Dr. Francisco Javier Muñoz i Carrillo

Colorectal Cancer

RET alterations in medullary thyroid tumors by Dra. Carla Climent
Successful tailored treatment for an orphan tumor by Dra. Nuria Chic
Deciphering lobular breast carcinoma in the era of pecision medicina by Dra. Milana Bergamino
From Molecular Diagnosis to Molecular Imaging by Dra. Marta García de Herreros
Pathogenic co-mutations in the Homologous Recombination Repair (HRR) pathway: A case report in prostate cancer by Dr. Mauricio Tournour
Squamous NSCLC with Actionable Drivers by Angela Montes
When one Mutation isn't enought: The Genomic Challenge of BRCA, ESR1 and PIK3CA by Dra. Raquel Gomez